Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |